MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
569.30%
Quick Ratio
524.90%
Debt to Asset Ratio
19.86%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Intangible assets, net
Operating lease right-of-use ass...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Operating lease liabilities, non...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
502,512
490,285
473,966
432,508
Marketable securities
49,521
49,563
49,443
49,576
Accounts receivable, net
47,545
39,031
47,013
43,779
Other receivables
3,084
17,106
35,480
52,813
Inventory
52,616
53,487
56,341
61,956
Prepaid expenses and other current assets
19,393
20,261
22,208
19,195
Total current assets
674,671
669,733
684,451
659,827
Property and equipment, net
215,324
220,591
226,711
232,534
Restricted cash
-
-
-
201
Operating lease right-of-use assets
56,685
58,390
60,450
63,650
Goodwill
6,918
4,511
4,511
4,511
Intangible assets, net
61,160
59,910
62,329
64,759
Other noncurrent assets
15,308
2,624
2,913
1,879
Total assets
1,030,066
1,015,759
1,041,365
1,027,361
Contingent consideration, current
-
-
23,363
23,723
Accounts payable
20,694
17,425
12,733
18,069
Accrued compensation and related benefits
24,744
21,506
42,500
37,084
Accrued expenses and other current liabilities
30,377
33,680
39,971
35,766
Deferred revenue
23,610
24,342
23,902
22,139
Operating lease liabilities
12,015
11,330
10,985
10,543
Contingent consideration, current
7,069
5,315
-
-
Total current liabilities
118,509
113,598
153,454
147,324
Contingent consideration, noncurrent
2,991
1,222
1,237
1,210
Operating lease liabilities, noncurrent
66,781
70,059
73,376
76,442
Deferred revenue, noncurrent
9,683
10,138
10,501
10,871
Other noncurrent liabilities
6,556
6,418
6,471
6,394
Total liabilities
204,520
201,435
245,039
242,241
Preferred stock
0
0
-
0
Common stock
2
2
2
2
Additional paid-in capital
2,367,459
2,338,269
2,306,690
2,279,319
Accumulated deficit
-1,541,992
-1,524,061
-1,510,591
-1,494,339
Accumulated other comprehensive income
77
114
225
138
Total stockholders equity
825,546
814,324
796,326
785,120
Total liabilities and stockholders equity
1,030,066
1,015,759
1,041,365
1,027,361
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$502,512K
(26.35%↑ Y/Y)
Inventory
$52,616K
(-23.71%↓ Y/Y)
Marketable securities
$49,521K
(-0.06%↓ Y/Y)
Accounts receivable, net
$47,545K
(-4.87%↓ Y/Y)
Prepaid expenses and
other current assets
$19,393K
(-4.77%↓ Y/Y)
Other receivables
$3,084K
(-95.54%↓ Y/Y)
Total current assets
$674,671K
(2.90%↑ Y/Y)
Property and equipment,
net
$215,324K
(-10.17%↓ Y/Y)
Intangible assets, net
$61,160K
(315.66%↑ Y/Y)
Operating lease
right-of-use assets
$56,685K
(-9.59%↓ Y/Y)
Other noncurrent
assets
$15,308K
(472.48%↑ Y/Y)
Goodwill
$6,918K
(53.36%↑ Y/Y)
Total assets
$1,030,066K
(5.11%↑ Y/Y)
Total liabilities and
stockholders equity
$1,030,066K
(5.11%↑ Y/Y)
Total stockholders
equity
$825,546K
(6.76%↑ Y/Y)
Total liabilities
$204,520K
(-1.05%↓ Y/Y)
Accumulated deficit
-$1,541,992K
(-5.12%↓ Y/Y)
Additional paid-in capital
$2,367,459K
(5.69%↑ Y/Y)
Total current
liabilities
$118,509K
(5.60%↑ Y/Y)
Operating lease
liabilities, noncurrent
$66,781K
(-13.36%↓ Y/Y)
Deferred revenue,
noncurrent
$9,683K
(-14.08%↓ Y/Y)
Other noncurrent
liabilities
$6,556K
(7.04%↑ Y/Y)
Contingent consideration,
noncurrent
$2,991K
Accumulated other
comprehensive income
$77K
(-65.00%↓ Y/Y)
Common stock
$2K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$30,377K
(-22.24%↓ Y/Y)
Accrued compensation
and related...
$24,744K
(-5.20%↓ Y/Y)
Deferred revenue
$23,610K
(10.08%↑ Y/Y)
Accounts payable
$20,694K
(29.84%↑ Y/Y)
Operating lease
liabilities
$12,015K
(24.26%↑ Y/Y)
Contingent consideration,
current
$7,069K
Buy us a coffee
10x Genomics, Inc. (TXG)
10x Genomics, Inc. (TXG)